Maximize Your Impact At EBIO 2026
EBIO 2026, set for May 31 at Expo Guadalajara in Jalisco, brings together biotechnology leaders, health science innovators, and ecosystem stakeholders for a high-impact event focused on scientific development, business acceleration, and regional innovation. This summit is a critical touchpoint for Latin American and global decision-makers driving advances in bio-industrial technologies, pharma supply chains, clinical research, agribiotech, and sustainable solutions.
Attendees include CEOs, R&D leads, investors, public officials, and academics—all united by a shared focus on discovery and commercialization. Many are active buyers scouting new partners, allocating R&D funding, and evaluating tech solutions at a strategic level. The event’s concentrated format supports direct engagement with key stakeholders who are shaping operational and capital decisions in real time.
Using the Vendelux enriched attendee list, teams can identify investors, policy influencers, and biopharma executives before the event begins. Early outreach to this network increases your chances of securing in-person meetings with high-intent prospects and building momentum for long-term collaboration.
How Sales, Marketing And Revops Teams Can Use This Attendee List
EBIO 2026 presents a unique environment for business development teams targeting biotech firms, research centers, and public-private partnerships. The attendee data enables commercial teams to identify roles with grant oversight, product sourcing mandates, or technology adoption responsibility.
Segmenting contacts by organization type—governmental institutions, private labs, multinational suppliers—allows for message precision. Use the enriched conference attendee list to focus on heads of lab operations, corporate development directors, or innovation officers who are planning purchases or scouting collaborations.
Pre-event outreach to budget holders can drive more meetings and higher on-site engagement. Follow up with references to scientific themes, pilot project timelines, or ecosystem partnerships that match the attendee’s focus. This tactical use of conference attendees enables more qualified pipeline conversations, better conversion paths, and lasting relationships beyond the event.
Timing Is Everything
EBIO 2026 takes place on May 31, 2026. Outreach in Q4 2025 and early Q1 2026 will yield better access to C-level attendees and programs still in planning phases. Using Vendelux, your team can gain early access to predictive attendee data to align timing with high-value outreach.
Flag key accounts and identify internal champions weeks before others know they’re attending. This advantage helps you secure strategic meetings long before inboxes fill up. Sync your campaign plans and sales sequences with event dates to maximize ROI from both virtual and in-person engagement.
What’s Included In The EBIO 2026 Attendee List?
Vendelux provides visibility into executives expected to attend EBIO 2026 through a combination of organizer-supplied data and predictive intelligence. Clients can upload a list of priority accounts to detect matches within the event audience.
The enriched list contains first and last name, job title, company name, company website, geographic location (city, state, country), LinkedIn profile, verified email addresses, and phone numbers where available.
Where Is EBIO 2026?
EBIO 2026 will take place at Expo Guadalajara in Guadalajara, Jalisco, Mexico.
When Is EBIO 2026?
The event is scheduled for May 31, 2026.
What Type Of Event Is EBIO 2026?
EBIO 2026 is a biotechnology and health science conference that centers on innovation, public-private collaboration, and bioregional growth. The event features expert panels, keynote presentations, startup showcases, and guided networking sessions designed for entrepreneurs, corporates, institutions, and researchers operating in the bioeconomy.
How Many People Attend EBIO 2026?
EBIO 2026 is expected to welcome over 1,000 attendees from across Latin America and beyond. The audience includes executive-level participants, institutional decision-makers, research professionals, and industry partners across biotechnology, pharmaceuticals, agritech, and health policy.
